Document is current
Any future updates will be listed below
-
Authors
Bruch, Julius
Xu, Hong
Rösler, Thomas W
De Andrade, Anderson
Kuhn, Peer‐Hendrik
Lichtenthaler, Stefan F
Arzberger, Thomas
Winklhofer, Konstanze F
Müller, Ulrich
Höglinger, Günter U https://orcid.org/0000-0001-7587-6187
-
Funding
Funding for this research was provided by:
Bavarian Research Foundation (DOK‐145‐12)
Deutsche Forschungsgemeinschaft (HO2402/6‐2)
Deutsche Forschungsgemeinschaft (EXC 1010)
Bundesministerium für Bildung und Forschung (JPND RiMOD‐FTD)
Research Award of the Breuer Foundation
NOMIS Foundation (DZNE FTLD project)
- License Information
-
More Information
Article History
Received: 6 June 2016
Revised: 22 December 2016
Accepted: 23 December 2016
First Online: 1 February 2017
Conflict of interest
: A patent application describing PERK activation as treatment strategy for tauopathies is pending (J.B., T.W.R., G.U.H.).
